Who Paid My Doc Search
Menu
Product Program year 2024 Source: CMS Open Payments

ACCLARENT Balloon Inflation Device

Device Rhinology Laryngology

PDI 10705031063570

Open in the dashboard

General payments

$681,156

706 payments

Research payments

$0

0 payments

Through program year 2024, $681,156 in general payments and $0 in research payments were reported against ACCLARENT Balloon Inflation Device (Rhinology Laryngology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $13,446 31
2023 General $198,522 232
2022 General $224,173 252
2021 General $245,015 191

Breakdown

Who paid General payments · program years 2021–2024
  1. Acclarent, Inc $673,210 691 payments
  2. Medical Device Business Services, Inc. $7,716 2 payments
  3. Janssen Biotech, Inc. $105 7 payments
  4. Biosense Webster, Inc. $84 1 payment
  5. Janssen Pharmaceuticals, Inc $40 5 payments
Top recipients General payments · program year 2024
  1. Vanderbilt University Medical Center Teaching hospital · TN $4,000 30% · 1 payment
  2. Langley Porter Psychiatric Hospital Teaching hospital · CA $3,500 26% · 1 payment
  3. Dennis Poe Otolaryngology · Boston, MA $2,700 20% · 1 payment
  4. Kenneth Hsu Otolaryngology · Plano, TX $147 1% · 1 payment
  5. Nimish Patel Otolaryngology · Round Rock, TX $147 1% · 1 payment

The top 5 of 31 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Otolaryngology $3,868 67% · 10 practitioners
  2. Neurological Surgery $1,605 28% · 12 practitioners
  3. Nurse Practitioner $170 3% · 3 practitioners
  4. Radiation Oncology Radiology $134 2% · 1 practitioner
  5. Gastroenterology Internal Medicine $36 <1% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Tennessee $4,000 30% · 1 recipient
  2. California $3,634 27% · 2 recipients
  3. Massachusetts $2,700 20% · 1 recipient
  4. Minnesota $1,471 11% · 11 recipients
  5. Texas $589 4% · 4 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

Records

706 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record